Список использованной литературы.
1. Горелов А.В., Усенко Д.В. (2003) Влияние пробиотического продукта «Актимель» на
состояние здоровья детей. «Вопросы современной педиатрии», т. 2, №4, с. 87-90.
2. Дранник Г.Н. (2004). Роль Toll-like рецепторов в активации неспецифического
иммунитета и перспективы новых фармакотерапевтических разработок. «Вісник
фармакології та фармації», №12, 2-14.
3. Мечников И.И. (1988) Этюды оптимиста. Москва, 327с.
4. Харченко Н.В., Черненко В.В. (2000) Современные подходы к коррекции дисбиоза
кишечника (Методические рекомендации), Киев, 2000, 28 стр.
5. Aattouri.N. and Lemonier.D. (1997) Production of interferon induced by Streptococcus
thermophilus: role of CD4+ and CD8+ lymphocytes. Nutr Biochem 8, 25-31.
6. Abren M.T., Vora P., Faure E. et al (2001) Decreased expression of Toll-like receptor-4 and
MD-2 correlates with
intestinal epithelial cell protection agantist dysregulated
proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol.
167, 1609-16.
7. Alander M., Satokari R., Korpela R. et al. 1999. Persistence of colonization of human
colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption.
Appl. Environ. Microbiol. 65:351-4.
8. Armuzzi.A.,
Cremonini.F.,
Bartolozzi.F.,
Canducci.F.,
Candelli.M.,
Ojetti.V.,
Cammarota.G., Anti.M., De LorenzoA, Pola.P., Gasbarrini,G. and Gasbarrini.A.
(2001) The effect of oral administration of Lactobacillus GG on antibioticassociated gastrointestinal side-effects during Helicobacter pylori eradication
therapy. Aliment. Pharmacol. Ther. 15, 163-169.
9. Arvola.T., Laiho.K., Torkkeli.S., Mykkanen.H., Salminen.S., Maunula.L. and lsolauri,E.
(1999) Prophylactic Lactobacillus
GG
reduces
antibiotic-associated
diarrhea
in
children with respiratory infections: a randomized study. Pediatrics 104, e64.
10. Bassetti S, Frei Zimmerli W. 1998. Fungemia with Saccharomyces cerevisiae after treatment
with Saccharomyces boulardii. Am. J. Med. 105:71-2.
11. BelleyA, Keller.K., Gottke.M., Chadee.K. and Goettke.M. (1999) Intestinal mu cins in
colonization and host defense
in
against
pathogens
[published
erratum
appears
Am.J.Trop.Med.Hyg.1999 Jun;60(6):1062]. Am. J. Trop. Med. Hyg. 60, 10-15.
12. Bennet.R., Eriksson,M., Nord.C.E. and Zetterstrom.R. (1986) Fecal bacterial microflora
of newborn infants during intensive care management and treatment with five antibiotic
regimens. Pediatr. Infect. Dis. 5, 533-539.
2
13. Benno Y., He F, Hosoda M. 1996. Effect of Lactobacillus GG yoghurt on human intestinal
microecology in Japanese subjects. Nutr. Today. 31 (suppl): 9S-11S.
14. Bernasconi, P. (1984) The intestinal flora and ecosystem. Lab.Biocodex.
15. Bernet.M.F., Brassart,D., Neeser.J.R. and Servin,A.L. (1994) Lactobacillus acidophilus
LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell
invasion by enterovirulent bacteria. Gut 35, 483-489.
16. Bertazzoni - Minelli E et al. (1993). Bacterial faecal flora in healthy women of different
ages. Microb EcologyHealth Dis; 6(2): 43-51.
17. Biller.JA, Katz.A.J., Flores.A.F., Buie.T.M. and Gorbach.S.L. (1995) Treatment of
recurrent Clostridium difficile colitis with Lactobacillus GG. J. Pediatr. Gastroenterol.
Nutr. 21, 224-226.
18. Bischoff S.C., Mayer J.H. & Manns M.P. 2000. Allergy and the gut. Int. Arch. Allergy
Immunol. 121: 270-283.
19. Bjorksten.B., Naaber,P., Sepp.E. and Mikelsaar.M. (1999) The intestinal microflora in
allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29, 342-346.
20. Black.F., Einarsson.K.,
Lidbeck.A., Orrhage.K. and Nord.C.E. (1991) E ffect of
lactic acid producing bacteria on the human intestinal microflora during ampicillin
treatment. Scand. J. Infect. Dis. 23, 247-254.
21. Borruel N et al. (2002). Increased mucosal TNF alpha production in Crohn's disease can be
downregulated ex vivo by probiotic bacteria. Gut, 5: 659-664.
22. Borruel N et al. (2003). Effect on non pathogenic bacteria on cytokine secretion by human
colonic mucosa. Am J Gastro, 98: 865-870.
23. Borruel N., Casellas F., Antolin M., Llopis M., Carol M., Espfin E., Naval J., Guarner F.,
Malagelada J.R. (2003) Effect of nonpathogenic bacteria on cytokine secretion by human
instestinal mucosa. “Amer. J. of Gastroenterology”, v.98, N4, 865-870.
24. Bourlioux, Koletzko, Guarner et al. (2003). The intestine and its microflora are partners for
the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held
in Paris, June 14, 2002 American Journal of Clinical Nutrition; Vol. 78, No. 4: 675-683.
25. Bousavos A, Guandalini S, Baldassano , Botelho C, Evans J, Ferry GD, Goldin
B, Hartigan L, Kugathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR,
Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL. A randomize, double blind trial
of Lactobacillus GG versus placebo in addition to standard maintenance therapy for
children with Crohn's disease. Inflamm Bowel Dis. 2005, 11(9); 833-839.
26. Boyle Robert J., Roy M. Robins-Browne, Mimi LK Tang. 2006. Probiotic use in clinical
practice: what are the risks? Am. J. Clin. Nutr. 83:1256-64.
3
27. Brook I. (1999) Bacterial interference. Crit Rev. Microbiol. 25, 155-172.
28. Cebra JJ (1999). Influences of microbiota on intestinal immune system development. J Am
Clin Nutr ; 69 (suppl) : S1046-1051
29. Chapat L et al. (2004). Lactobacillus casei reduces CD8+ T cell-mediated skin
inflammation. European Journal of Immunology, 34: 2520-2528.
30. Christensen HR, Frokiaer H, Pestka JJ. 2002. Lactobacilli differentially modulate expression
of cytokines and maturation surface marjers in murine dendritic cells. J. Immunol. 168:1718.
31. De Groote MA, Frank DN, Dowell E., Glode MP, Pace NR. 2005. Lactobacillus rhamnosus
GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr.
Infect. Dis. J. 24:278-80.
32. De Simone, C, Bianchi Salvadori, B., Jirillo, E., Baldinelli, L., Bitonti, F. and Vesely, R.
(1989) Modulation of immune activities in humans and animals by dietary lactic
acid bacteria, ed. In: Chandan RC.Ed.Y.n.a.h.p.M.V.K.L. pp. 201-214
33. De Simone,C, Bianchi Salvadori,B., Negri.M., Ferrazzi.M., Baldinelli,L. and Vesely,R.
(1986) The adjuvant affect of yoghurt on production of gamma-interferon by Con A
stimulated human peripheral blood lymphocytes. Nutr Rep Int 33, 419-433.
34. Djouzi Z et al. (1997). The association of yogurts starters with Lactobadtlus casei DN 114001 in fermented milk alters the composition and metabolism of intestinal microflora in
germ-free rats and in human flora-associated rats. Journal of Nutrition, 127: 2260-2266.
35. Fabia.R., Ar'Rajab.A., Johansson,M.L., Willen.R., Andersson.R., Molin.G. and
Bengmark.S. (1993) The effect of exogenous administration of Lactobacillus reuteri
R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand. J. Gastroenterol.
28, 155-162. Falk.P.G., Hooper.L.V., Midtvedt.T. and Gordon.J.I. (1998) Creating and
maintaining the gastrointestinal ecosystem: what we know and need to know from
gnotobiology. Microbiol. Mol. Biol. Rev. 62, 1157-1170.
36. Farina C., Arosio M., Mangia M., Moioli F. (2001) Lactobacillus casei subsprhamnosus
sepsis in a patient with ulcerative colitis. “J. Clin. Gastroenterol.”, 33, 251-252.
37. Farstad, I. N., Halstensen, T. S., Lazarovits, A. I., Norstein, J., Fausa, O. and Brandtzaeg, P.
(1995) Scand. J. Immunol., 42, 662-672.
38. Federak R., Gionchetti P., Campieri M. (2003) VSL3 probiotic mixture induces remission in
patients with active ulcerative colitis (abstr.) “Gastroenterology”, 124, A377.
39. Felley.C.P.,
Corthesy-Theulaz.l.,
Rivero.J.L.,
Sipponen,P.,
Kaufmann.M.,
Bauerfeind.P., Wiesel.P.H., Brassart.D., Pfeifer.A., Blum.A.L. and Michetti.P. (2001)
4
Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.
Eur. J. Gastroenterol. Hepatol. 13, 25-29.
40. Fioramonti J., Theodoron V., Bueno L. (2003) Probotics: what are they? What are their
effects on gut physiology? “Best Pract. Res. Clin. Gastroenterol.”, 17, 711-724.
41. Gill.H.S., Rutherfurd.K.J., Prasad.J. and Gopal P.K. (2000) Enhancement of natural
and
acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus
acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr S3, 167-176.
42. Gill.H.S., Rutherfurd.K.J. and Cross,M.L. (2001) Dietary probiotic supplementation
enhances natural killer cell activity in the elderly: an investigation of age-related
immunological changes. J. Clin. Immunol. 21, 264-271.
43. Gill.H.S., Rutherfurd.K.J., Cross.M.L. and Gopal.P.K. (2001) Enhancement of immunity
in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis
HN019. Am. J. Clin. NutrlA, 833-839.
44. Gionchetti.P., Rizzello.F., Helwig U. et al (2003) Prophylaxic of pouchitis onset with
probiotic therapy: a double-blind, placebo-controlled trial. “Gastroenterology”, 124,
1202-1209.
45. Gionchetti.P., Rizzello.F., Venturi.A. et al (2000) Oral bacteriotherapy as maintenance
treatment in patients with chronic pouchitic: a double-blind, placebo-controlled trial.
“Gastroenterology”, 119, 305-309.
46. Gionchetti.P., Rizzello.F., Venturi.A., Matteuzzi.D., Rossi,M., Peruzzo.S., Poggioli.G.,
Bazzocchi.G. and Campieri.M. (1998) Maintenance treatment of chronic pouchitis: a
randomized, placebo controlled, double-blind trial with a new probiotic preparation
(abstr). Gastroenterology 114.
47. Gorbach.S.L., Chang.T.W. and Goldin.B. (1987) Successful treatment of relapsing
Clostridium difficile colitis with Lactobacillus GG. Lancet 2, 1519.
48. Guandalini.S.,
Pensabene.L.,
Zikri.M.A.,
Dias.J.A.,
Casali.L.G.,
Hoekstra.H.,
Kolacek.S., Massar.K., Micetic-Turk.D., Papadopoulou.A., de Sousa.J.S., Sandhu.B.,
Szajewska.H. and Weizman.Z. (2000) Lactobacillus GG administered in oral
rehydration solution to children with acute diarrhea: a multicenter European trial. J.
Pediatr. Gastroenterol. Nutr. 30, 54-60.
49. Guarino.A., Canani.R.B., Spagnuolo.M.I., Albano.F. and Di Benedetto,L. (1997) Oral
bacterial therapy reduces the duration of symptoms and of viral excretion in
children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr. 25, 516-519.
5
50. Guerin-Danan C et al. (1998). Milk fermented with yogurt cultures and Lactobacillus casei
DN 114-001 compared with yogurt and jellied milk: influence on the intestinal microflora in
healthy infants. Am 3 Clin Nutr, 67: 111-117.
51. Hatakka.K., Savilahti.E., Ponka.A., Meurman.J.H., Poussa.T., Nase.L., Saxelin.M. and
Korpela.R. (2001) Effect of long term consumption of probiotic milk on infections in
children attending day care centres: double blind, randomised trial. BMJ 322, 1327.
52. Havenaar R ef al. Survival of lactobacilli strains in a dynamic computer controlled in
vitro model of the gastrointestinal tract. Lactic 94, Caen, France 7-9 September 1994.
53. He.F., Tuomola.E., Arvilommi.H. and Salminen.S. (2000) Modulation of humoral
immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 29, 47-52.
54. Hilton,E., Kolakowski.P., Singer.C. and Smith,M. (1997) Efficacy of Laptobacillus
GG as a Diarrheal Preventive in Travelers. J. Travel. Med. 4, 41-43.
55. Holt P.G. 1995. Postnatal maturation of immune competence during infancy and childhood.
Pediatr. Allergy Immunol. 6: 59-70.
56. Hylander M.A., Strobino D.M. & Dhanireddy R. 1998. Human milk feedings and infection
among very low birth weight infants. Pediatrics 102: E38 (pp.6, electronic paper).
57. Ingrassia I, Leplingard A, Darfeuille-Michaud A.( 2005); Lactobacillus casei DN 114-001
inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease
patients to adhere to and to invade intestinal epithelial cells.
58. Isolauri E et al. (2002). Role of probiotics in food hypersensitivity. Curr Opin Allergy Clin
Immunol, 2: 263-271.
59. Isolauri.E., Arvola.T., Sutas.Y., Moilanen.E. and Salminen.S. (2000) Probiotic s in the
management of atopic eczema. Clin. Exp. Allergy 30, 1604-1610.
60. Isolauri.E., Juntunen.M., Rautanen.T., Sillanaukee.P. and Koivula.T. (1991) A human
Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute
diarrhea in children. Pediatrics 88, 90-97.
61. Jones Jennifer L., Foxx-Orenstein Amy E. (2007) The role of probiotics in inflammatory
bowel disease. “Dig. Dis. Sci”, 52, 607-611.
62. Kalliomaki.M., Salminen.S., Arvilommi.H., Kero,P., Koskinen.P. and Isolauri.E. (2001)
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.
Lancet 357, 1076-1079.
63. Kampman.E., van,V, Hiddink.G.J., Aken-Schneijder,P., Kok.F.J. and Hermus.R.J.
(1994) Fermented dairy products, dietary calcium and colon cancer: a case- control
study in The Netherlands. Int J Cancer 59, 170-176.
6
64. Katz J., Pirovano F., Mateuzzi D.E.A. (2002) Commercially available probiotic
preparationce: are you getting what are you pay for? “Gastroenterology”, 122, A459.
65. Kunz AN, Noel JM, Fairchok MP. 2004. Two cases of Lactobacillus bacteremia during
probiotic treatment of short gut syndrome. J. Pediatr. Gastroenterol. Nutr. 38:457-8.
66. Lidbeck.A., Overvik.E., Rafter.J., Nord.C.E. and Gustafsson.J.A. (1992) Effect of
Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in
humans. Microbial Ecol Health Dis. 5, 59-67.
67. Lin.M.Y., Savaiano.D. and Harlander.S. (1991) Influence of nonfermented dairy
products containing bacterial starter cultures on lactose maldigestion in humans. J.
Dairy Sci. 74, 87-95.
68. Link-Amster,H., Rochat.F., Saudan.K.Y., Mignot.O. and Aeschlimann.J.M. (1994)
Modulation of a specific humoral immune response and changes in intestinal flora
mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10, 55-63.
69. Llopis M, Antolin M, Guarner F, et al. (2005). Mucosal colonisation with Lactobacillus
casei DN 114-001 mitigates barrier injury induced by exposure to trinitronbenzene
sulphonic acid. Got; 54: 955-959.
70. Lumen after one intake of fermented milk. Annals of Nutrition & Metabolism, 47: 645.
71. Luquet F.M., Corrieu G. (2005) Lactic bacteria and probiotics. Lavoisier, 106pp.
72. Mack.D.R.,
Probiotics
Michail.S.,
Wei,S.,
McDougall.L.
and
Hollingsworth.M.A.
(1999)
inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal
mucin gene expression. Am. J. Physiol 276, G941-G950.
73. Mackay A.D., Tayljr M.B., Kibbler C.C., Hamilton-Miller J.M. 1999. Lactobacillus
endocarditis caused by a probiotic organism. Clin. Microbiol. Infect. 5:290-2.
74. Majamaa H., Isolauri E. 1997. Probiotics: a novel approach in the management of food
allergy. J. Allergy Clin. Immunology. 99:179-85.
75. Majamaa.H. and lsolauri,E. (1997) Probiotics: a novel approach in the management of
food allergy. J.Allergy Cliri. Immunol. 99, 179-185.
76. Mao,Y., Nobaek,S., Kasravi.B., Adawi.D., Stenram.U., Molin.G. and Jeppsson.B.
(1996) The effects of Lactobacillus strains and oat fiber on methotrexate- induced
enterocolitis in rats. Gastroenterology 111, 334-344.
77. Marcos A et al. (2004). The effect of milk fermented by yogurt cultures plus Lactobacillus
casei DN 114-001 on the immune response of subjects under academic examination stress.
European Journal of Nutrition, Volume 43, Number 6, December 2004 Pages: 381-389.
78. Marteau.P. and Rambaud.J.C. (1993) Potential of using lactic acid bacteria
for therapy and immunomodulation in man. FEMS Microbiol. Rev. 12, 207-220.
7
79. McCartney AL, Wenzhi W, Tannock GW. 1996. Molecular analysis of the composition of
the bifidobacterial and lactobacillus microflora of humans. Appl. Envirol. Microbiol.
62:4608-13.
80. Meance,S., Cayuela.C, Turchet.P., Raimondi.A., Lucas,C. and Antoine.J.M. (2001) A
fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened oro-fecal
gut transit time in elderly. Microbial Ecol Health Dis. 13,217-222.
81. Medici M, Vinderola CG, Weill R, et al. (2005) Effect of fermented milk containing
probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in
mice. J Dairy Research; 72: 243-249.
82. Mercenier A., Pavan S., Pot B. (2003) Probiotics as biotherapeutic agents: present
knowledge and future prospects. “Curr. Pharm. Des”, 9, 175-191.
83. Meyer A.L., Micksche M., Herbacek I., Elmadfa I. (2006). Daily intake of probiotiic as well
as conventional yogurt has a stimulating effect on cellular immunity in young healthy
women. Ann.Nutr.Metab., 50:282-289.
84. Meydani.S.N. and Ha.W.K. (2000) Immunologic effects of yogurt. Am. J. Clin. Nutr. 71,
861-872.
85. Michel FB (1994). Psychology of the allergic patient. Allergy, 49: 28-30.
86. Michetti,P.,
Dorta.G., Wiesel.P.H.,
Brassart.D., Verdu.E.,
Herranz,M.,
Felley.C.,
Porta.N., Rouvet.M., Blum.A.L. and Corthesy-Theulaz.I. (1999) Effect of whey-based
culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori
infection in humans. Digestion 60, 203-209.
87. Oggioni MR, Pozzi G, Valensin PE, Galieni P., Bigazzi C. 1998. Recurrent septicemia in an
immunocompromised patients due to probiotic strains of Bacillus subtilis. J. Clin.
Microbiol. 36:325-6.
88. Oozer R ef al. (2003). Kinetic of living Lactobacillus casei DN 114-001 recovery in human
ileal
89. Oozer R et al. (2002). Lactobacillus casei DIM 114-001 is able to survive and initiate
protein synthesis during its transit in the digestive tract of human flora-associated mice.
Applied and Environmental Microbiology, 7: 3570-3574.
90. Orrhage.K., Brismar.B. and Nord.C. (1994) Effect of supplements with Bifidobacterium
longum and Lactobacillus acidophilus on the intestinal microbiota during administration
of clindamycin. Microbial Ecol Health Dis. 7, 17-25.
91. Orrhage.K., Sjostedt.S. and Nord.C.E. (2000) Effect of supplements with lactic acid
bacteria and oligofructose on the intestinal microflora during administration of
cefpodoxime proxetil. J. Antimicrob. Chemother. 46, 603-612.
8
92. Ouwehand Arthur C. (2007) Antiallergic effect of probiotics. “J. Nutr.”, 794S-797S.
93. Owen, R. L. (1999) Semin. Immunol., 11,157-163.
94. Parassol N, Freitas M, Thoreux K, ef al. (2005); Lactobacillus casei DN 114-001 inhibits
the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84
cells. Res Microbiol.; 156(2):256-62.
95. Parassol N, Freitas M, Thoreux K, ef al. (2005); Lactobacillus casei DN 114-001 inhibits
the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84
cells. Res Microbiol.; 156(2):256-62.
96. Parra D, Martinez de Morentin B, Cobo JM, etal. (2004). Monocyte function in healthy
middle-aged people receiving fermented milk containing Lactobacillus casei J Nutr Health
and Aging; 8(4): 208-211.
97. Parra MD, Martinez de Morentin BE, Cobo JM, etal. (2004). Daily ingestion of fermented
milk containing Lactobacillus casei DN 114-001 improves innate defence capacity in
healthy middle-aged people. J Physiol Biochem; 60(2): 85-92
98. Pedone CA ef al. (1999). The effect of supplementation with milk fermented by
Lactobacillus casei (strain DN 114-001) on acute diarrhoea in children attending day care
centres. Int 3 Clin Practice, 53: 179-184. 67.
99. Pelto L, Isolauri E., Lilius EM, Nuutila J, Salminen S. 1998. Probiotic bacteria downregulate the milk-induced inflammatory response in milk-hypersensitive subjects but have
an immunostimulatory effect in healthy subject. Clin. Exp. Allergy. 28:1474-9.
100.
Pessi T, Sutas Y, Hurme M, Isolauri E. 2000. Interleukin-10 generation in atopic
children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy. 30:1804-8.
101. Pessi.T., Isolauri.E., Sutas.Y., Kankaanranta.H., Moilanen.E. and Hurme.M. (2001)
Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein.
Int Immunopharmacol. 1, 211-218.
102.
Pochard P., Gosset P, Grangette C. et al. 2002. Lactic acid bacteria inhibit Th2
cytokine production by mononuclear cells from allergic patients. J. Allergy Clin.
Immunology. 110:617-23.
103. Prantera.C, Scribano.M.L., Falasco.G., Andreoli.A. and Luzi.C. (2002) Ineffectiveness
of probiotics in preventing recurrence after curative resection for Crohn's disease: a
randomised controlled trial with Lactobacillus GG. Gut 51, 405-409.
104. Pujol P ef al. (2000). The effect of fermented milk containing Lactobacillus casei on the
immune response to exercise. Training and Rehab, 9: 209-223.
105. Pujol P etal. (2000). The effect of fermented milk containing Lactobacillus casei on the
immune response to exercise. Training and Rehab, 9: 209-223.
9
106. Rochet V ef al. (2006). Effects of orally administered Lactobacillus casei DN 114-001 on
the composition and activities of the dominant faecal flora microbiota in healthy humans. Br
3 Nutr, 95: 421-429
107. Rolfe.R.D. (2000) The role of probiotic cultures in the control of gastrointestinal health.
J. Nutr. 130, 396S-402S.
108.
Rosenfeldt V, Benfeldt E, Paerregaard A, Michaelsen KF. 2004. Effect of probiotic
on gastrointestinal symptoms and small intestinal permeability in children with atopic
dermatitis. J.Pediatr. 145:612-6.
109. Ruseler-van Embden.J.G., van Lieshout.L.M., Gosselink.M.J. and Marteau.P.
(1995) Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium
bifidum to degrade intestinal mucus glycoproteins. Scand. J. Gastroenterol. 30, 675-680.
110. Saavedra.J.M., Bauman.NA, Oung.l., Perman.J.A. and Yolken.R.H. (1994) Feeding
of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for
prevention of diarrhoea and shedding of rotavirus. Lancet 344, 1046-1049.
111. Sartor R. (2005) Probiotic therapy of intestinal inflammation and infections. “Curr. Opin.
Gastroenterol.”, 21, 44-50.
112. Savaiano.DA, AbouEIAnouar.A., Smith,D.E. and Levitt.M.D. (1984) Lactose
malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured
milk in lactase-deficient individuals. Am. J. Clin. Nutr. 40, 1219-1223.
113.
Saxelin M, Elo S, Salminen S, Vapaatalo H. 1991. Dose response colonization of
faeces after oral administration of Lactobacillus casei strain GG. Microbial. Ecol. Health
Dis. 4:209-14.
114. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in
prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebocontrolled trials. Lancet Infect Dis. 2006 Jun;6(6):374-82.
115. Schiffer-Mannioni C., Dif F., van der Moer A., Daëron M. (2007). Lactobacillus casei
defensis inhibits IgE-induced mast cell activation. Presented as an oral communication in:
WAC
(World
Allergy Congress),
Bagkok,
Thailand,
2-6
December.
Contact:
dif@danone.com
116. Schiffrin,E.J.,
Rochat.F.,
Link-Amster,H.,
Aeschlimann.J.M.
and
Donnet-
Hughes.A. (1995) Immunomodulation of human blood cells following the ingestion of
lactic acid bacteria. J. Dairy Sci. 78, 491-497.
117.
Sepp E., Mikelsaar M, Salminen S. 1993. Effect of Lactobacillus casei strain GG
administration on the gastrointestinal microbiota of newborns. Microbial. Ecol. Health Dis.
6:309-14.
10
118. Sgouras D, Maragkoudakis P., Petraki K. et al (2004) In vitro and in vivo inhibition of
Helicobacter pylori by Lactobacillus casei strain Shirota. “Appl.Environ.Microbiol.” 70,
518-526.
119. Sieber.R. and Dietz.U.T. (1998) Lactobacillus acidophilus and yogurt in the
prevention and therapy of bacterial vaginosis. Int. Dairy J. 8, 599-607.
120.
Spinosa MR, Wallet F, Courcol RJ, Oggioni MR. 2000. The trouble in tracing
opportunistic pathogens: cholangitis due to Bacillus in a French hospital caused by a strain
related to an Italian probiotic? Microb. Ecol. Health. Dis. 12:99-101.
121.
Steidler L., Neirynck S, Huyghebaert N. et al. 2003. Biological containment of
genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat.
Biotechnol. 21:785-9.
122. Sykora j, Valeckova K, Amlerova J, e tal. (2005). Effects of a Specially Designed
Fermented Milk Product Containing Probiotic Lactobacillus casei DN 114-001 and the
Eradication of H. pylori in Children. J Clin Gastroenterol 2005; 39 (8): 692-698
123. Tanabe H, Shirafuji Y, Thoreux K ef al. (2004); Lactobacillus casei DN 114-001 indues
Paneth cell secretion and is sensitive to enteric defensisns. J Gastroenterol. 126, 4, S2: A
578.
124. Thoreux K et al. (1998). Diet supplemented with yogurt or milk fermented by
Lactobacillus casei DN 114-001 stimulates growth and brushborder enzyme activities in
mouse small intestine. Digestion, 59: 349-359.
125. Tien MT, Girardin S, Regnault B, et al. (2006). Anti-inflammatory effect of Lactobacillus
casei DN 114-001 on Shigella-infected human intestinal epithelial cells. J Immunol 176:
1228-1237.
126. Turchet P et al. (2003). Effect of fermented milk containing the probiotic Lactobacillus
casei DN 114-001 on winter infection in free-living elderly subjects: a randomised,
controlled pilot study. Journal of Nutrition, Health and Ageing, 7: 75-77. 97.
127. Van Niel.C.W., Feudtner.C, Garrison,M.M. and Christakis.D.A. (2002) Lactobacillus
therapy for acute infectious diarrhea in children: a meta- analysis. Pediatrics 109, 678684.
128. Venturi A., Gionche Hi P., Rizzello F. et al (1999) Impact on the composition of the faecal
flora by a new probiotic preparation: preliminary data on maintenance treatment of patients
with ulcerative colitis. “Aliment Pharmacol Ther”, 13, 1103-1108.
129. Vitini.E.,
Alvarez,S.,
Median,M.,
Medici,M.,
Budeguer.M.
and
Perdigon.G.
(2001) Gut mucosal immunostimulation by lactic acid bacteria. Biocell 24, 223-232.
11
130. Wachtershauser A., Loitsch S.M., Stein J. (2000). PPAR-gamma is selectively
upregulated in Caco-2 cells by butyrate. “Biochem. Biophys. Res. Commun.”, 272, 38085.
131.
Wagner R.D., Warner T., Roberts L., Farmer J., Balish E. 1997. Colonization of
congenitally immunodeficient mice with probiotic bacteria. Infect. Immun. 65:3345-51.
132.
Wagner RD, Pierson C, Warner T. et. Al. 1997. Biotherapeutic effects of probiotic
bacteria on candidiasis in immunodeficient mice. Infect. Immun. 65:4165-72.
133.
Young SL, Simon MA, Baird MA et al. 2004. Bifidobacterial species differentially
affect expression of cell surface markers and cytokines of dendritic cells harvested from
cord blood. Clin. Diagn. Lab. Immunol. 11:686-90.